References
- Morrow A. L., Creese I. Characterization of α1-adrenergic receptor subtypes in rat brain: A reevaluation of [3H]WB4101 and [3H]prazosin binding. Mol. Pharmacol. 1986; 29: 321–330
- Han C., Abel P. W., Minneman K. P. α1-Adrenoceptor subtypes linked to different mechanisms for increasing intracellular Ca2+ in smooth muscle. Nature 1987; 329: 333–335
- Han C., Abel P. W., Minneman K. P. Heterogeneity of α1-adrenergic receptors revealed by chlorethylclonidine. Mol. Pharmacol. 1987; 32: 505–510
- Minneman K. P. α1-Adrenergic receptor subtypes, inositol phosphates, and source of cell Ca2+. Pharmacol. Rev. 1988; 40: 87–119
- Hanft G., Gross G. Subclassification of α1-adrenoceptor recognition sites by urapidil derivatives and other selective antagonists. Br. J. Pharmacol. 1989; 97: 691–700
- Muramatsu I., Kigoshi S., Oshita M. Two distinct α1-adrenoceptor subtypes involved in noradrenaline contraction of the rabbit thoracic aorta. Br. J. Pharmacol. 1990; 101: 662–666
- Muramatsu I., Ohmura T., Kigoshi S., Hashimoto S., Oshita M. Pharmacological subclassification of α1-adrenoceptor in vascular smooth muscle. Br. J. Pharmacol. 1990; 99: 197–201
- Muramatsu I., Kigoshi S., Ohmura T. Subtypes of α1-adrenoceptors in noradrenaline-induced contractions of rat thoracic aorta and dog carotid artery. Japan J. Pharmacol. 1991; 57: 535–544
- Li Y.-O., Nichols A. J., Ruffolo R. R., Jr. Evidence for α1-adrenoceptor promiscuity in the rat aorta. Pharmacologist 1991; 33: 225
- Han C., Minneman K. P. Interaction of subtype-selective antagonists with α1-adrenergic receptor binding sites in rat tissues. Mol. Pharmacol. 1991; 40: 531–538
- Oshita M., Kigoshi S., Muramatsu I. Three distinct binding sites for [3H]-prazosin in the rat cerebral cortex. Br. J. Pharmacol. 1991; 104: 961–965
- Ohmura T., Oshita M., Kigoshi S., Muramatsu I. Identification of α1-adrenoceptor subtypes in the rat vas deferens: binding and functional studies. Br. J. Pharmacol. 1992; 107: 697–704
- Lomasney J. W., Cotecchia S., Lefkowitz R. J., Caron M. G. Molecular biology of α-adrenergic receptors: implications for receptor classification and for structure-function relationships. Biochim. Biophys. Acta. 1991; 1095: 127–139
- Perez D. M., Piascik M. T., Graham R. M. Solution-phase library screening for the identification of rare clones: Isolation of an α1D-adrenergic receptor cDNA. Mol. Pharmacol. 1991; 40: 876–883
- Hiramatsu Y., Muraoka R., Kigoshi S., Muramatsu I. 5–Methylurapidil may discriminate between α1-adrenoceptors with a high affinity for WB4101 in rat lung. Br. J. Pharmacol. 1992; 105: 6–7
- Munson P. J., Rodbard D. LIGAND: A versatile computerized approach for characterisation of ligand-binding systems. Anal. Biochem. 1980; 107: 220–239
- Bradford M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976; 72: 248–254
- Kinami J., Tsuchihashi H., Baba S., Mano F., Maruyama K., Nagatomo T. α1-Adrenoceptor subtypes in the rat ventricular muscle. J. Pharm. Pharmacol. 1992; 44: 97–100
- Gross G., Hanft G., Rugevics C. 5–Methylurapidil discriminates between subtypes of the α1-adrenoceptor. Eur. J. Pharmacol. 1988; 151: 333–335
- Schwinn D. A., Lomasney J. W., Lorenz W., Szklut P. J., Fremeau R. T., Jr., Yang-Feng T. L., Caron M. G., Lefkowitz R. J., Cotecchia S. Molecular cloning and expression of the cDNA for a novel α1-adrenergic receptor subtype. J. Biol. Chem. 1990; 265: 8183–8189
- Schwinn D. A., Lomasney J. W. Pharmacological characterization of cloned α1-adrenoceptor subtypes: selective antagonists suggest the existence of a fourth subtype. Europ. J. Pharmacol. 1992; 227: 433–436
- Lomasney J. W., Cotecchia S., Lorenz W., Leung W. Y., Schwinn D. A., Yang-Feng T. L., Brownstein M., Lefkowitz R. J., Caron M. G. Molecular cloning and expression of the cDNA for the α1A-adrenergic receptor. J. Biol. Chem. 1991; 266: 6365–6369
- Minneman K. P., Han C., Abel P. W. Comparison of α1-adrenergic receptor subtypes distinguished by chlorethylclonidine and WB4101. Mol. Pharmacol. 1988; 33: 509–514